Outcomes in pediatric relapsed/refractory anaplastic large cell lymphoma: A multi-institutional retrospective analysis

被引：0
|
作者：
Marks, Lianna Jean
Ritter, Victor
Schultz, Liora M.
Lowe, Eric J.
Aftandilian, Catherine
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA USA
[2] Childrens Hosp Kings Daughters Surg Grp, Norfolk, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10032
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis
    Zacharoulis, Stergios
    Ashley, Sue
    Moreno, Lucas
    Gentet, Jean-Claude
    Massimino, Maura
    Frappaz, Didier
    CHILDS NERVOUS SYSTEM, 2010, 26 (07) : 905 - 911
  • [22] Cytogenetic Analysis of Pediatric Anaplastic Large Cell Lymphoma
    Mussolin, Lara
    Pillon, Marta
    Bonato, Paola
    Leszl, Anna
    Franceschetto, Genny
    Di Meglio, Annamaria
    d'Amore, Emanuele S. G.
    Sainati, Laura
    Rosolen, Angelo
    PEDIATRIC BLOOD & CANCER, 2010, 55 (03) : 446 - 451
  • [23] Radiation Therapy for Primary Cutaneous Anaplastic Large Cell Lymphoma: An International Lymphoma Radiation Oncology Group Multi-institutional Experience
    Million, Lynn
    Yi, Esther J.
    Wu, Frank
    Von Eyben, Rie
    Campbell, Belinda A.
    Dabaja, Bouthaina
    Tsang, Richard W.
    Ng, Andrea
    Wilson, Lynn D.
    Ricardi, Umberto
    Kirova, Youlia
    Hoppe, Richard T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (05): : 1454 - 1459
  • [24] FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma
    Merino, Margret
    Kasamon, Yvette
    Li, Hongshan
    Ma, Lian
    Leong, Ruby
    Zhou, Jiaxi
    Reaman, Gregory
    Chambers, Wiley
    Richardson, Nicholas
    Theoret, Marc
    Pazdur, Richard
    Gormley, Nicole
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [25] Brentuximab in Children, Adolescent and Young Adults with Relapsed/Refractory Anaplastic Large Cell Lymphoma
    Vinti, Luciana
    Merli, Pietro
    Agolini, Emanuele
    Stocchi, Francesca
    Lucarelli, Barbarella
    Girardi, Katia
    Algeri, Mattia
    Boccieri, Emilia
    Lodi, Mariachiara
    Becilli, Marco
    Cefalo, Maria Giuseppina
    BLOOD, 2022, 140 : 12141 - 12142
  • [26] Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL)
    Chen, Mei-ting
    Fu, Xiao-hong
    Huang, He
    Wang, Zhao
    Fang, Xiao-jie
    Yao, Yu-Yi
    Ren, Quan-Guang
    Chen, Ze-geng
    Lin, Tong-yu
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 571 - 580
  • [27] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis
    Merchionne, Francesca
    Quintana, Giovanni
    Gaudio, Francesco
    Minoia, Carla
    Specchia, Giorgina
    Guarini, Attilio
    Quarta, Giovanni
    Pavone, Vincenzo
    Melpignano, Angela
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1446 - 1450
  • [28] Clinical Characteristics and Outcomes of Pediatric Systemic Anaplastic Large Cell Lymphoma
    Moron-Ocana, Juan-Manuel
    Monsalve-Sosa, Pablo
    Martinez-Barranca, Maria-Luisa
    Coronel-Perez, Isabel-Maria
    Perez-Gil, Amalia
    PEDIATRIC DERMATOLOGY, 2025,
  • [29] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study
    Fukuhara, Noriko
    Yamamoto, Go
    Tsujimura, Hideki
    Chou, Takaaki
    Shibayama, Hirohiko
    Yanai, Tomoko
    Shibuya, Kazunori
    Izutsu, Koji
    LEUKEMIA & LYMPHOMA, 2020, 61 (01) : 176 - 180
  • [30] Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma-Response
    Knoerr, Fabian
    Woessmann, Wilhelm
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (01) : 107 - 108
12345